- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05188768
Growth Factors in the Localized Gingival Recessions Treatment
Clinical Effects of Concentrated Growth Factor and Platelet-Rich Fibrin in the Treatment of Localized Gingival Recessions: A Split-Mouth Randomized Clinical Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Gingival recession (GR) is a common mucogingival deformity. The root surface (RS) exposed by GR is treated with various surgical techniques.Traditionally, if GT and height of the keratinized gingiva (KG) are sufficient, the coronally advanced flap (CAF) technique is commonly used to close the exposed RS.Platelets contain various growth factors (GFs) to initiate healing process or regeneration of tissue.The second generation of platelet concentrates is platelet-rich fibrin (PRF) that are obtained from the centrifugation of blood (2700/3000rpm for 12 min) without anticoagulant or bovine trombin.And, the third generation of platelets concentrates is concentrated growth factor (CGF) as a new approach to produce PRF.It stated that the modified speed during centrifugation contribute the dense fibrin matrix in which includes larger, more intensive, more GFs than PRF.CGF is considered to be a biomaterial that is better than PRF in bone regeneration, but there is no study compare the clinical effects of CGF and PRF in the treatment of localized GRs. Our study hypothesized that if CGF has better regenerative capacity than PRF, the use of CGF in the treatment of GRs as a natural biomaterial may enhace the percentage of RC or healing of soft tissue compared with PRF. Therefore, the purpose of this study was to compare clinical effects of CGF and PRF in the treatment of localized GRs.
The patients of this randomized, split-mouth and controlled clinical trial study protocol were selected from individuals referred to the Department of Periodontology, at the Faculty of Dentistry, Bulent Ecevit University, for either dentin hypersensitivity or aesthetic complaints between April 2015 and June 2017.
The subjects were enrolled to this study based on the following inclusion criteria: (1) age > 18 years, (2) systemically and periodontally healthy, (3) non-smokers, (4) presence of ≥2 buccal adjacent Miller Class I or II GR with ≥2 mm GR depth (RD), probing depth (PD) <3 mm and gingival thickness (GT) ≥1 mm on both sides of the maxillary arch, (5) width of keratinized gingiva (KGW) ≥2 mm, (6) presence of identifiable cemento-enamel junction CEJ, (7) central, lateral canine and premolar teeth with GRs in the maxilla (8) full-mouth plaque control record (PCR) ≤20% (O'Leary et al. 1972) and gingival index (GI) scores = 0 (Loe, 1967) and presence of tooth vitality and absence of caries, restorations and furcation involvement in the treated area.
All the subjects received oral hygiene instructions and full-mouth scaling were performed 1 month before surgery. They were instructed to perform a non-traumatic brushing technique (Roll) using an ultra-soft toothbrush. In eighteen patients (mean age 39.67₊10.25 age; 8 females, 10 males), one side of the jaw received PRF+ CAF (37 defects), the opposite site received CGF + CAF (39 defects).
Application of PRF membrane to the control region: The patient's venous blood was taken into the 10-ml test tubes and placed quickly in the Electro-Mag centrifuge (M 815 P, İstanbul, Turkey) without shaking. The device was operated at 2700 rpm for 12 minutes to obtain PRF. Application of CGF membrane to the test region: The intravenous blood of the patient was taken into 10-ml glaas-coated test tubes without anticoagulant solutions and rapidly centrifuged with a CGF centrifuge machine (Medifuge, Silfradent, S. Sofia, Italy). The instrument's CGF program was selected and operated at speeds and angles ranging from 2700 to 3000 rpm. After approximately 13 minutes of rotation, CGF was obtained. CGF is characterized by 4 phases: (1) serum in the top layer, (2) the second buffy coat layer, (3) the third GF and unipotent stem cell layer (CGF), (4) the lower red blood cell layer (RBC). The CGFand PRF clot was removed from the tube and separated from the RBC by using microsurgical scissors. The CGF was squeezed in a special box that produces membranes at a constant thickness of 1 mm.All surgeries were performed by the same expert periodontist during a single surgical session Gingival recession sites were randomly determined as either test or control site by tossing a coin immediately before the surgical procedure.
Sutures were removed after 10 days and plaque control was maintained by CHX for additional 2 weeks. The patients started brush the tooth at the end of the 3rd week and they were again instructed in mechanical tooth cleaning of the treated tooth using an ultra soft toothbrush and roll technique. Oral hygiene instructions were provided at each postoperative visit.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- systemically and periodontally healthy,
- non-smokers
- presence of Miller Class I and II gingival recession with ≥ 2 mm gingival recession depth , probing depth <3 mm and gingival thickness (GT) ≥ 1 mm on both sides of the maxillary arch
- width of keratinized gingiva ≥ 2mm
- presence of identifiable cemento-enamel junction
- full-mouth plaque index (PI) < 20 % and gingival index (GI) scores =1,
- presence of tooth vitality and absence of caries, restorations and furcation involvement in the treated area,
Exclusion Criteria:
- - patients who had systemic problems that wound contraindicate for periodontal surgery, - usage of medications known to interfere with healing and to cause gingival enlargement - recession defects associated with demineralization, deep abrasion,
- previous surgery in the defects area within the past 1 year,
- pregnant or lactating females
- drug and alcohol abuse
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Koncentreret vækstfaktormembran
Autogent blodplade- og leukocytfibrinmateriale blev opnået fra blod.
|
Koncentreret vækstfaktor frembringes ved centrifugering af venøst blod, og blodplader koncentreres i et gellag indeholdende fibrinmatrix
Andre navne:
Blodpladerige fibrinis fremstillet ved centrifugering af venøst blod og blodplader koncentreres i et gellag indeholdende fibrinmatrix
Andre navne:
|
|
Aktiv komparator: Blodpladerigt fibrin
Autogent blodplade- og leukocytfibrinmateriale blev opnået fra blod.
|
Koncentreret vækstfaktor frembringes ved centrifugering af venøst blod, og blodplader koncentreres i et gellag indeholdende fibrinmatrix
Andre navne:
Blodpladerige fibrinis fremstillet ved centrifugering af venøst blod og blodplader koncentreres i et gellag indeholdende fibrinmatrix
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Fuldstændig roddækning
Tidsramme: 6 måneder
|
Ændring fra baseline i procent af fuldstændig roddækning efter 6. måned.
|
6 måneder
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Recessionsdybde
Tidsramme: 6 måneder
|
Afstanden er fra cemento-emaljeforbindelsen til tandkødsranden
|
6 måneder
|
|
Percentage of mean root coverage
Tidsramme: 6 months
|
Change from baseline in percentage ofmean root coverage at 6th months.
|
6 months
|
|
Keratinized gingiva width
Tidsramme: 6 months
|
The distance is from the cemento-enamel junction to the gingival margin
|
6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 36290600/38
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Lokaliseret gingival recession
-
University Hospital, GhentRekrutteringGingival recession, mucogingival kirurgi | Gingival recession, generaliseret | Gingival recession, lokaliseret | Gingival recession, plastikkirurgi | Gingival recessioner | Gingival recession Generaliseret Moderat | Gingival recession Lokaliseret moderatBelgien
-
University Hospital, GhentRekrutteringGingival recession, mucogingival kirurgi | Gingival recession | Gingival recession, lokaliseret | Gingival recession, plastikkirurgi | Gingival recession Lokaliseret moderatBelgien
-
University Hospital, GhentMediplus Ltd UKRekrutteringGingival recession, mucogingival kirurgi | Gingival recession, lokaliseret | Gingival recession, plastikkirurgi | Gingival recessionerBelgien
-
Istanbul Aydın UniversityAfsluttetGingival recession, mucogingival kirurgi | Gingival recession, generaliseret | Gingival recession, lokaliseretKalkun
-
Bulent Ecevit UniversityAfsluttetGingival recession, lokaliseretTyrkiet (Türkiye)
-
Ain Shams UniversityAktiv, ikke rekrutterendeGingival recession, lokaliseretEgypten
-
Universidade do PortoRegedent AG, ZürichIkke rekrutterer endnuGingival recession, mucogingival kirurgiPortugal
-
Dokuz Eylul UniversityAktiv, ikke rekrutterendeGingival recession, mucogingival kirurgi | Gingival recessionerTyrkiet (Türkiye)
-
Minia UniversityIkke rekrutterer endnuGingival sygdomme | Gingival recession, lokaliseret | Recession, Gingival
-
King Abdullah University HospitalJordan University of Science and Technology; Deanship of Scientific Research...Aktiv, ikke rekrutterendeGingival recession, mucogingival kirurgiJordan
Kliniske forsøg med Koncentreret vækstfaktormembran
-
Cairo UniversityIkke rekrutterer endnuPeriapisk radiolucens | Odontectomy (Tandudtrækning) | Sokkelbevaring og heling efter simpel, ikke-kirurgisk ekstraktion | Alveolær Knogletæthed og Postoperativ SmertebehandlingEgypten
-
Nourhan M.AlyAlexandria UniversityAfsluttetTemporomandibulære ledlidelser | Temporomandibulær lidelseEgypten
-
Tanta UniversityAktiv, ikke rekrutterendeTandimplantater | GingivaEgypten
-
Roswell Park Cancer InstituteAfsluttetLungebetændelse | Kronisk obstruktiv lungesygdom | Ikke-småcellet lungekarcinom | Stadie II lungekræft AJCC v8 | Stadie IIA lungekræft AJCC v8 | Stadie IIB lungekræft AJCC v8 | Stadie IIIA Lungekræft AJCC v8 | Stadie IB lungekræft AJCC v8Forenede Stater
-
Institute of Dermatology, ThailandChumsaeng ChumsaengsriAfsluttet
-
National Cancer Institute (NCI)Afsluttet
-
MallinckrodtAfsluttet
-
Becton, Dickinson and CompanyAfsluttetPræoperativ hudforberedelseForenede Stater
-
RenovoTrukket tilbage
-
Roswell Park Cancer InstituteAktiv, ikke rekrutterendeMetastatisk lunge ikke-småcellet karcinom | Stadie IVA lungekræft AJCC v8 | Stadie IVB lungekræft AJCC v8 | Ikke-småcellet lungekarcinom | Stadie III lungekræft AJCC v8 | Stadie IV lungekræft AJCC v8 | Stadie IIIA Lungekræft AJCC v8 | Stadie IIIB Lungekræft AJCC v8 | Tilbagevendende hoved- og halspladecellekræft og andre forholdForenede Stater